Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-03-06
Original SEC Filing: Click here

---

Webplus: SVA/20180306/6-K/2_EX-99.1/000.htm SEC Original: tv487857_ex99-1.htm
Sinovac Announces Re-Election of All Directors at Annual General Meeting Asks Delaware Court of Chancery to Determine Whether Dissident Shareholders Triggered Sinovac’s Shareholder Rights Plan Board Approves Extension of Shareholder Rights Plan to March 27, 2019 Company Files Lawsuit in Federal District Court against Dissident Shareholders BEIJING, March 5, 2018 /PRNewswire/ Mr. Weidong Yin, Chairman, President and CEO of the

---

---

Webplus: SVA/20180306/6-K/3_EX-99.2/000.htm SEC Original: tv487857_ex99-2.htm
Sinovac Announces Enhancement of Corporate Governance and Management of China Operating Entity BEIJING, March 5, 2018 /PRNewswire/ Sinovac Biotech (Hong Kong) Limited, a wholly owned subsidiary of the Company, has appointed Mr. Dawei Mao, Chairman of Zhongke Biopharmaceutical Co., Ltd., as a director of Sinovac Beijing. He has replaced Ms. Xiaomin Yang, the President of Sinobioway Group Co., Ltd. Mr.

---

---

Webplus: SVA/20180306/6-K/1/000.htm SEC Original: tv487857_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-03-06CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085